MapLight Therapeutics, Inc. (MPLT)

11.85 -0.69 (-5.50%) USD  |  NASDAQ  |  Aug 26, 12:00
More

MapLight Therapeutics Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for MPLT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2025. Start Trial.
Date Value
August 17, 2026 --
August 14, 2026 --
August 13, 2026 --
July 30, 2026 --
July 28, 2026 --
July 27, 2026 --
July 24, 2026 --
July 22, 2026 --
July 21, 2026 --
July 20, 2026 --
July 10, 2026 --
June 24, 2026 --
June 23, 2026 --
June 22, 2026 --
June 21, 2026 --
June 01, 2026 --
May 28, 2026 --
Date Value
May 21, 2026 --
May 20, 2026 --
May 18, 2026 --
May 15, 2026 --
May 14, 2026 --
May 04, 2026 --
April 22, 2026 --
April 08, 2026 --
April 07, 2026 --
March 27, 2026 --
March 26, 2026 --
March 19, 2026 --
March 16, 2026 --
December 07, 2025 --
December 05, 2025 --
December 04, 2025 --
November 21, 2025 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Evommune, Inc. --
Sarepta Therapeutics, Inc. Upgrade
Cullinan Therapeutics, Inc. Upgrade
Mineralys Therapeutics, Inc. Upgrade
Apogee Therapeutics, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade